Skip to main content

Table 2 Comparison between patients with EFT< 5 mm and those ≥ 5 regarding risk factors, NLR and VWF

From: New stroke prognostic factors

ItemsEFT< 5(n = 25) No. (%)EFT≥5(n = 35) No. (%)TestP value
Age Mean ± SD56.72 ± 5.0061.03 ± 5.61t = 3.070.003*
Sex:    
 Males12 (48.0)20 (57.1)χ2 = 0.490.484
 Females13 (52.0)15 (42.9)  
Smoking5 (20.0)14 (40.0)  
No20 (80.0)21 (60.0)χ2 = 2.700.101
Hypertension6 (24.0)19 (54.3)χ2 = 5.50 
No hypertension19 (76.0)16 (45.7) 0.019*
DM9 (36.0)11 (31.4)  
No DM16 (64.0)24 (68.6)χ2 = 0.140.711
Hypercholesterolemia:3 (12.0)23 (65.7)  
No22 (88.0)12 (34.3)χ2 = 17.14< 0.001*
BMI (≥ 25)2 (8.0)18 (51.4)  
Normal23(92.0)17 (48.6)χ2 = 12.38< 0.001*
AF2(8.0)6 (17.1)  
No AF23 (92.0)29 (82.9)χ2 = 1.050.304
Carotid stenosis4 (16.0)11 (24.4)  
No21 (84.0)24 (75.6)χ2 = 1.850.174
Combined risk06 (17.1)  
No25 (100.0)29 (82.9)χ2 = 4.760.029*
Hyperurecemia4 (16.0)4 (11.4)  
No21 (84.0)21 (88.6)χ2 = 0.260.608
VWF:Ag (μml) (Mean ± SD)9.95 ± 2.1411.57 ± 2.43t = 2.670.010*
NLR< 213 (52.0)12 (34.3)χ2 = 1.880.170
NLR ≥ 212 (48.0)23 (65.7)  
  1. *Means highly significant